A federal court has upheld a ruling that biotech company Illumina should pay rival Syntrix $115 million and an 8 percent running royalty rate for patent infringement.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
syntrix, illumina, array, judge benjamin settle